Fuwei Films Announces Fourth Quarter and Full Year 2007 Financi... ( Teleconference to be...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results

Date:4/14/2008

Teleconference to be Held at 8:30 a.m. EDT

BEIJING, April 14 /Xinhua-PRNewswire-FirstCall/ -- Fuwei Films (Holdings) Co. Limited (Nasdaq: FFHL) (''Fuwei'' or ''the Company''), a manufacturer and distributor of high-quality BOPET plastic films in China, today announced the financial results for the fourth quarter and full year ended December 31, 2007.

Financial Results Highlights

-- Revenues for 2007 rose 2.9% to US$59.1 million (RMB 449.4 million) from

2006;

-- Revenues of specialty films in 2007 rose 6.1% from 2006 to US$22.4

million (RMB 170.0 million), or 37.8% of total revenues;

-- Revenues from overseas in 2007 soared 23.9% from 2006 to US$15.0

million (RMB 114.2 million), or 25.4% of total revenues;

-- Gross margin was 22.2% in 2007, as opposed to 23.5% in 2006;

''We are pleased to report a solid year of decent top-line growth and further buildup of our research team,'' said Xiaoan He, Chairman and CEO of Fuwei Films. ''Our exports saw strong expansion, due to our enhanced efforts to market overseas. And we continued to grow sales of higher-margin specialty films, even though we have been facing a challenging operating environment since the second half of 2007, exemplified by higher raw material costs and the capital shortfall for our Third Production Line of thick films.''

Mr. He continued, ''Going forward, we will keep using our newly strengthened R&D platform and our Trial Production Line to commercialize products. Finally, we believe that our enhanced foreign marketing campaigns are positioning us to yield encouraging results in new markets.''

Fourth Quarter Financial Results

Revenues for the fourth quarter of 2007
'/>"/>

SOURCE Fuwei Films (Holdings) Co. Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Related medicine news :

1. Fuwei Films Announces Third Quarter 2007 Financial Results
2. Fuwei Films to Convene Annual Shareholders Meeting On December 21 in New York City
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting

Post Your Comments:

(Date:3/14/2014)... experience, and those affected by one often feel that ... life after a stroke is therefore about reestablishing life ... very rarely possible and thus a source of frustration ... of Copenhagen who has interviewed a number of patients ... PhD thesis was carried out in collaboration with a ...

(Date:3/14/2014)... Patient requests for specific medicationsincluding requests for brand-name ... on doctors, prescribing decisions, suggests a study in the ... The journal is published by Lippincott Williams ... Health . , "A patient request for a specific ... prescribe that medication," according to the new research led ...

(Date:3/14/2014)... University of Adelaide has confirmed that a gene ... of the development of human brains. , Known as ... for more than a decade, but in recent years scientists ... , In a new paper published online in the ... research team led by the University of Adelaide,s Robinson ...

(Date:3/13/2014)... revolutionary University of Colorado Boulder toilet fueled by ... some of the 2.5 billion people around the ... unveiled in India this month. , The self-contained, ... grant from the Bill & Melinda Gates Foundation, ... a high enough temperature to sterilize human waste ...

(Date:3/13/2014)... chasing down a hard-hit ball or a lesser mortal ... a close watch on your surroundings when walking or ... suggests that the body may get help in these ... visual system neurons to fire more strongly during locomotion. ... on changes among different brain states during sleep, but ...

Breaking Medicine News(10 mins):Health News:Stroke patients may benefit from new routines 2 Health News:Patient requests for specific drugs have major impact on prescribing, reports study in Medical Care 2 Health News:Patient requests for specific drugs have major impact on prescribing, reports study in Medical Care 3 Health News:Critical role of one gene to our brain development 2 Health News:Innovative solar-powered toilet developed by CU-Boulder ready for India unveiling 2 Health News:Innovative solar-powered toilet developed by CU-Boulder ready for India unveiling 3 Health News:Innovative solar-powered toilet developed by CU-Boulder ready for India unveiling 4 Health News:These boosts are made for walkin' 2

[0] Stroke patients may benefit from new routines [0] Patient requests for specific drugs have major impact on prescribing, reports study in Medical Care [0] Critical role of one gene to our brain development [0] Innovative solar-powered toilet developed by CU-Boulder ready for India unveiling [0] These boosts are made for walkin'

... /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals,a developer and manufacturer of ... the appointment of David B. Holtz as Vice,President ... In these,roles, Mr. Holtz will be responsible for ... Information Technology reporting to,Thomas E. Gardner, Chairman and ...

... 7 Conseco, Inc. (NYSE: CNO ),today reported ... set a new quarterly sales record with an increase ... Prieur said. "This performance included,an 11% increase at Bankers ... increase in total sales including new product offerings) of ...

... be swaying clinicians , , WEDNESDAY, May 7 ... say researchers at Rhode Island Hospital and Brown ... of patients previously diagnosed with bipolar disorder were ... the Structured Clinical Interview for DSM-IV (SCID). , ...

... problems, study finds, , , WEDNESDAY, May 7 (HealthDay News) ... face an increased risk of complications, even if the ... gestational diabetes. , In a large, international study, ... blood sugar, there was a greater risk of complications, ...

... -- Shire plc(LSE: SHP, Nasdaq: SHPGY), ... a major scientific meeting findings from analyses ... alpha-2A-agonist. This compound, is an investigational once-daily ... of the symptoms of Attention Deficit Hyperactivity ...

... PRINCETON, N.J., May 7 Derma Sciences, Inc.,(OTC Bullentin ... to release its first quarter 2008 results before market ... conference call that same,day to discuss the results at ... (domestic) or 617 213 8846 (international), with passcode,26916332 to ...

NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer Conseco Reports First Quarter Results Bipolar Disorder Might Be Overdiagnosed High Blood Sugar Tied to Pregnancy Complications Shire investigational nonstimulant INTUNIV showed significant efficacy in reducing ADHD symptoms Derma Sciences Announces Date of Its First Quarter 2008 Earnings Release and Conference Call on May 15, 2008

(Date:1/15/2014)... Jan. 15, 2014 Massachusetts General Hospital ... AMGN ) announced today that they have ... validate new therapeutic targets and develop novel therapies ... that affects millions worldwide. The MGH-Broad-Amgen collaboration brings ... biology, human genetics, genomic technology, and drug discovery ...

(Date:1/15/2014)... LOUISVILLE, Ky. , Jan. 15, 2014 ... medical-related products and technologies must be able ... intellectual property (IP). (Logo: ... the highly-competitive nature of the Medical Device ... most litigious industry sectors of cases involving ...

(Date:1/15/2014)... PHILADELPHIA , Jan. 15, 2014 Echo ... a medical device company developing its Symphony® CGM ... system, today announced that Robert F. Doman ... Therapeutics, will present at "TEN", Noble Financial Capital ... Mr. Doman will make a corporate presentation to ...

Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2 Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3 Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4 Intellectual Property Insurance for Medical-related Products and Services 2 Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2 Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3

[0] Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease [1] Intellectual Property Insurance for Medical-related Products and Services [0] Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference

... ViaCyte, Inc. today announced the appointment of Michael ... Development, reporting to John West, President and Chief Executive ... device development and manufacturing activities, including design, engineering, and ... in the device area and to the overall leadership ...

... EndoSphere Inc. , a medical technology company ... patents, announced today that the U.S. Patent and Trademark ... use of its endoscopically implantable devices for the treatment ... U.S. Patent number 7,931,693 titled "Method and ...

Cached Medicine Technology:ViaCyte Names Michael Scott Vice President, Device Research & Development 2 EndoSphere Inc. Receives Patent for Obesity Treatment 2

ViaCyte Names Michael Scott Vice President, Device Research & Development EndoSphere Inc. Receives Patent for Obesity Treatment

... has developed a minimally invasive cryocatheter ... It delivers a very high level ... pinpoint site precision, minimal tissue disruption, ... stenosis., ,Freezor is a flexible, single-use, ...

The Valve Mapper Steerocath-Dx has a unique "peanut" shaped tip. It is designed to conform to the anatomy during mapping procedures. Both 8F/8mm and 8F/6mm tips are available....

... incorporates six electrodes which are spaced to ... catheter. Positioned in the Right Atrium, the ... electrograms. The catheter may then be repositioned ... recording and ventricular pacing and recording. If ...

... for a complete line of diagnostic coronary ... with the quality, reliability and precise performance ... in catheter technology. All of our coronary ... to help minimize the frustration and excess ...

Medicine Products:

Freezor 1 Valve Mapper Steerocath-Dx Catheters Webster Porterfield Deflectable Catheter Webster Luminal Decapolar (Coronary Sinus Fixed Curve Catheters)